Statistics for Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective

Total visits

views
Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective 0

Total visits per month

views
March 2025 0
April 2025 0
May 2025 0
June 2025 0
July 2025 0
August 2025 0
September 2025 0